New insights into diosgenin biosynthesis pathway and its regulation in Trigonella foenum-graecum L
- PMID: 31469464
- DOI: 10.1002/pca.2887
New insights into diosgenin biosynthesis pathway and its regulation in Trigonella foenum-graecum L
Abstract
Introduction: Throughout history, thousands of medicinal and aromatic plants have been widely utilised by people worldwide. Owing to them possessing of valuable compounds with little side effects in comparison with chemical drugs, herbs have been of interest to humans for a number of purposes. Diosgenin, driven from fenugreek, Trigonella foenum-graecum L., has extensively drawn scientist's attention owing to having curable properties and being a precursor of steroid hormones synthesis. Nonetheless, complete knowledge about the biosynthesis pathway of this metabolite is still elusive.
Objective: In the present research, we isolated the full-length CDS of 14 genes involving in diosgenin formation and measured their expression rate in various genotypes, which had illustrated different amount of diosgenin.
Methodology: The genes were successfully isolated, and functional motifs were also assessed using in silico approaches.
Results: Moreover, combining transcript and metabolite analysis revealed that there are many genes playing the role in diosgenin formation, some of which are highly influential. Among them, ∆24 -reductase, which converts cycloartenol to cycloartanol, is the first-committed and rate-limiting enzyme in this pathway. Additionally, no transcripts indicating to the presence or expression of lanosterol synthase were detected, contradicting the previous hypothesis about the biosynthetic pathway of diosgenin in fenugreek.
Conclusion: Considering all these, therefore, we propose the most possible pathway of diosgenin. This knowledge will then pave the way toward cloning the genes as well as engineering the diosgenin biosynthesis pathway.
Keywords: branch-point; diosgenin; fenugreek; gene expression; ∆24-reductase.
© 2019 John Wiley & Sons, Ltd.
References
REFERENCES
-
- McAnuff MA, Harding WW, Omoruyi FO, Jacobs H, Morrison EY, Asemota HN. Hypoglycemic effects of steroidal sapogenins isolated from jamaican bitter yam, dioscorea polygonoides. Food Chem Toxicol. 2005;43(11):1667-1672.
-
- Liagre B, Vergne-Salle P, Corbiere C, Charissoux JL, Beneytout JL. Diosgenin, a plant steroid, induces apoptosis in human rheumatoid arthritis synoviocytes with cyclooxygenase-2 overexpression. Arthritis Res Ther. 2004;6(4):R373-R383.
-
- Liu M-J, Wang Z, Ju Y, Wong RN-S, Wu Q-Y. Diosgenin induces cell cycle arrest and apoptosis in human leukemia K562 cells with the disruption of Ca2+ homeostasis. Cancer Chemother Pharmacol. 2005;55(1):79-90.
-
- Son IS, Kim JH, Sohn HY, Son KH, Kim J-S, Kwon C-S. Antioxidative and hypolipidemic effects of diosgenin, a steroidal saponin of yam (Dioscorea spp.), on high-cholesterol fed rats. Biosci Biotechnol Biochem. 2007;71(12):3063-3071.
-
- Ghosh S, More P, Derle A, et al. Diosgenin from Dioscorea bulbifera: novel hit for treatment of type II diabetes mellitus with inhibitory activity against α-amylase and α-glucosidase. PLoS ONE. 2014;9(9):e106039.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources